Target intelligence / Profile preview

Direct DNA damage via beta radiation

Molecular classification
Other
01

Overview

Direct DNA damage via beta radiation refers to the physical and chemical injuries sustained by cell DNA when exposed to beta particles. While the major component of beta radiation damage is indirect (mediated through ROS that create SSBs, DSBs, and base modifications), some direct DNA damage does occur when beta particles physically collide with DNA, ionizing atoms, breaking chemical bonds, and causing strand breaks. This damage triggers cellular DNA repair pathways (notably base excision repair and non-homologous end joining) or leads to cell cycle arrest, apoptosis, or permanent genomic instability. These molecular events underlie both the desired therapeutic effects (e.g., in cancer radiopharmaceuticals) and the key toxicities of beta-emitting agents, including the potential for secondary malignancies and normal tissue injury.

Other names
Beta-radiation induced DNA damageDNA lesions from beta particlesGenomic damage by beta radiation
02

Mechanism of action

Induction of DNA damage directly via ionization (breaking DNA strands or bases by direct collision/energy transfer); Generation of reactive oxygen species (ROS), causing indirect DNA damage; Induction of single-strand breaks (SSBs) and double-strand breaks (DSBs); Initiation of apoptosis via DNA damage response pathways.

03

Biological functions

Genome integrity maintenanceDNA repairCell cycle regulationApoptosisInduction of cell death pathways
04

Disease associations

CancerGenomic instabilityRadiation toxicity
05

Safety considerations

Normal tissue toxicityGenomic instabilitySecondary cancer developmentOff-target DNA damage
06

Interacting drugs

Beta-emitting radiopharmaceuticals (e.g., ^177Lu-DOTATATE, ^131I, ^90Y, ^89Sr)
07

Biomarkers

γ-H2AX foci53BP1 fociPARP activityFasL, FasR, Bcl-2, Bax, Caspase-3 (apoptosis pathway activation)

Beyond the preview

Go deeper on Direct DNA damage via beta radiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Direct DNA damage via beta radiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call